KRT5 and prostate cancer: From our analysis of the data set published by Singh et al. [16], prostate cancer subtypes that express lower levels of AR and PSA and higher levels of CK5 (that is, the basal type) and those with the opposite expression pattern (that is, the luminal type) apparently exist.